171 related articles for article (PubMed ID: 37090575)
1. Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data.
Lundin SK; Hu X; Feng J; Lundin KK; Chen Y; Tao C
Res Sq; 2023 Apr; ():. PubMed ID: 37090575
[TBL] [Abstract][Full Text] [Related]
2. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
Barthold D; Joyce G; Diaz Brinton R; Wharton W; Kehoe PG; Zissimopoulos J
PLoS One; 2020; 15(3):e0229541. PubMed ID: 32130251
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.
Deng Z; Jiang J; Wang J; Pan D; Zhu Y; Li H; Zhang X; Liu X; Xu Y; Li Y; Tang Y;
Hypertension; 2022 Oct; 79(10):2159-2169. PubMed ID: 35766029
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands.
Schroevers JL; Hoevenaar-Blom MP; Busschers WB; Hollander M; Van Gool WA; Richard E; Van Dalen JW; Moll van Charante EP
Lancet Reg Health Eur; 2024 Jul; 42():100927. PubMed ID: 38800111
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.
Ding J; Davis-Plourde KL; Sedaghat S; Tully PJ; Wang W; Phillips C; Pase MP; Himali JJ; Gwen Windham B; Griswold M; Gottesman R; Mosley TH; White L; Guðnason V; Debette S; Beiser AS; Seshadri S; Ikram MA; Meirelles O; Tzourio C; Launer LJ
Lancet Neurol; 2020 Jan; 19(1):61-70. PubMed ID: 31706889
[TBL] [Abstract][Full Text] [Related]
6. Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.
Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
Am J Nephrol; 2014; 40(2):174-83. PubMed ID: 25196154
[TBL] [Abstract][Full Text] [Related]
7. The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer's Disease.
Wang Y; Li M; Kazis LE; Xia W
JAR Life; 2023; 12():35-45. PubMed ID: 37441415
[TBL] [Abstract][Full Text] [Related]
8. Impacts of center and clinical factors in antihypertensive medication use after kidney transplantation.
Koraishy FM; Yamout H; Naik AS; Zhang Z; Schnitzler MA; Ouseph R; Lam NN; Dharnidharka VR; Axelrod D; Hess GP; Segev DL; Kasiske BL; Lentine KL
Clin Transplant; 2020 Mar; 34(3):e13803. PubMed ID: 31997429
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive Use and the Risk of Alzheimer's Disease and Related Dementias among Older Adults in the USA.
Pan X; Zhang D; Heo JH; Park C; Li G; Dengler-Crish CM; Li Y; Gu Y; Young HN; Lavender DL; Shi L
Drugs Aging; 2022 Nov; 39(11):875-886. PubMed ID: 36251143
[TBL] [Abstract][Full Text] [Related]
10. Lower dementia risk with different classes of antihypertensive medication in older patients.
van Middelaar T; van Vught LA; Moll van Charante EP; Eurelings LSM; Ligthart SA; van Dalen JW; van den Born BJH; Richard E; van Gool WA
J Hypertens; 2017 Oct; 35(10):2095-2101. PubMed ID: 28509727
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis.
den Brok MGHE; van Dalen JW; Abdulrahman H; Larson EB; van Middelaar T; van Gool WA; van Charante EPM; Richard E
J Am Med Dir Assoc; 2021 Jul; 22(7):1386-1395.e15. PubMed ID: 33460618
[TBL] [Abstract][Full Text] [Related]
12. Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk.
Liu JC; Hsu YP; Wu SY
PLoS One; 2016; 11(9):e0162588. PubMed ID: 27632175
[TBL] [Abstract][Full Text] [Related]
13. Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.
Mathes J; Kostev K; Gabriel A; Pirk O; Schmieder RE
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):173-83. PubMed ID: 20197011
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
[TBL] [Abstract][Full Text] [Related]
16. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.
Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ
J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-II stimulating vs. inhibiting antihypertensive drugs and the risk of Alzheimer's disease or related dementia in a large cohort of older patients with colorectal cancer.
Du XL; Li Z; Schulz PE
Front Cardiovasc Med; 2023; 10():1136475. PubMed ID: 37215552
[TBL] [Abstract][Full Text] [Related]
18. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
19. The Association Between the Prevalence, Medication Adherence and Control of Hypertension and the Prevalence of Mild Cognitive Impairment in Rural Northern China: A Cross-Sectional Study.
Ma LY; He F; Liu S; Wang XD; Gao Y; Shi Z; Niu J; Ji Y
Patient Prefer Adherence; 2022; 16():493-502. PubMed ID: 35228797
[TBL] [Abstract][Full Text] [Related]
20. Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
Du XL; Simpson LM; Osani MC; Yama JM; Davis BR
J Alzheimers Dis Parkinsonism; 2022; 12(3):. PubMed ID: 35571234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
